Ken Griffin’s Immunocore IMCR Stock Holding History

Ken Griffin’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,800	Closed	-$320K	–	13319
2025 Q3	$320K	Buy	+8,800	New	+$299K	﹤0.01%	10208
2025 Q2	–	Sell	-12,700	Closed	-$377K	–	13717
2025 Q1	$377K	Sell	12,700 -1,300	-9%	-$39K	﹤0.01%	9089
2024 Q4	$413K	Sell	14,000 -13,300	-49%	-$420K	﹤0.01%	8976
2024 Q3	$850K	Sell	27,300 -5,600	-17%	-$204K	﹤0.01%	7187
2024 Q2	$1.11M	Sell	32,900 -16,600	-34%	-$847K	﹤0.01%	6368
2024 Q1	$3.22M	Buy	49,500 +31,500	+175%	+$2.16M	﹤0.01%	4657
2023 Q4	$1.23M	Sell	18,000 -10,300	-36%	-$535K	﹤0.01%	6282
2023 Q3	$1.47M	Buy	28,300 +13,300	+89%	+$787K	﹤0.01%	5811
2023 Q2	$899K	Sell	15,000 -2,200	-13%	-$126K	﹤0.01%	6678
2023 Q1	$850K	Buy	17,200 +6,000	+54%	+$337K	﹤0.01%	7146
2022 Q4	$639K	Buy	11,200 +6,200	+124%	+$349K	﹤0.01%	7733
2022 Q3	$235K	Sell	5,000 -2,300	-32%	-$110K	﹤0.01%	10082
2022 Q2	$272K	Buy	+7,300	New	+$237K	﹤0.01%	10021

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Ken Griffin's IMCR Position: Q1 2026 in Review

Ken Griffin reduced its Immunocore (IMCR) stake by 1.7% in Q1 2026, selling an estimated $125K and leaving 230,399 shares worth $6.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3821.

Ken Griffin first reported a position in IMCR in Q1 2021 and has held it in 21 quarters since. The position peaked at $16.4M in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Ken Griffin held 230,399 shares of Immunocore worth $6.95M as of Q1 2026.
Ken Griffin sold 3,869 Immunocore shares in Q1 2026, an estimated $125K.
Immunocore made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #3821 holding.
Ken Griffin first reported a position in Immunocore in Q1 2021 and has held it in 21 quarters since.
Ken Griffin's Immunocore position peaked at $16.4M in Q4 2023.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.